Here is another way to calculate possible value. I do note. You could run 100’s scenarios
addressable market USA and Australia
30m plus 3m
say market penetration 5%. Now that is conservative!
= 1,650,000 clients
gross rev 1.650m x $1,500 = $2,475,000,000
say after paying a big pharmaceutical company we take home 30% = $742,500,000
now stay with me
$742,500,000/the shares on issue 230,000,000
that = PE $3.22
that times by say 20 (conservative for bio tech)
that equates to a value per share of $64.40
thats pretty crude and very conservative, but with a successful trial 3 in the USA and a TGA approval in Australia- the sky is the limit.
totally amazing, I know
glta
market penetration likely to be greater
cost of medication could easily be more than $1500
deal with big pharmaceutical could be far more lucrative
further global expansion
not to mention other treatments like mps etc.
my god...... I can’t air for trial 3 results.
- Forums
- ASX - By Stock
- research reports and media
Here is another way to calculate possible value. I do note. You...
-
- There are more pages in this discussion • 3,611 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAR (ASX) to my watchlist
|
|||||
Last
25.5¢ |
Change
-0.010(3.77%) |
Mkt cap ! $89.19M |
Open | High | Low | Value | Volume |
27.0¢ | 27.0¢ | 25.5¢ | $162.7K | 620.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 25008 | 25.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.0¢ | 34768 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 25008 | 0.255 |
8 | 215150 | 0.250 |
6 | 109763 | 0.245 |
7 | 91034 | 0.240 |
2 | 54200 | 0.235 |
Price($) | Vol. | No. |
---|---|---|
0.260 | 34768 | 1 |
0.270 | 500 | 1 |
0.275 | 6347 | 2 |
0.290 | 14580 | 3 |
0.295 | 10000 | 2 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |